The Head virion protein G6P (VI), also referred to as Coat protein D, is a minor coat protein located at the head of the Enterobacteria phage IKe viral particle. This protein is encoded by gene VI in the phage genome and performs crucial roles in maintaining phage structural integrity. The recombinant version of this protein is produced through genetic engineering techniques for research and analytical purposes. The protein is characterized by its UniProt accession number P03674 and consists of a complete amino acid sequence spanning positions 1-116 . Bacteriophages like IKe have evolved specialized protein structures that allow them to effectively infect bacterial hosts, with minor coat proteins like G6P (VI) contributing to this complex machinery.
In filamentous bacteriophages, structural proteins arrange in specific conformations to create the viral capsid that encapsulates the genomic material. The head virion protein G6P (VI) is located at one end of the phage particle, where it works in conjunction with other minor coat proteins to form the phage "head" structure. This architectural organization is critical for the phage's ability to protect its genetic material and successfully interact with host cells during infection .
The Head virion protein G6P (VI) derives its name from its gene designation (gene VI) and its function as a structural component (G6P) of the phage head. The protein is found in several related filamentous bacteriophages, including the extensively studied M13 and If1 phages, which share similar structural organizations. These filamentous phages belong to the family Inoviridae and specifically infect Enterobacteria hosts. The recombinant version of this protein is produced by expressing the gene in suitable host systems, typically E. coli, often with the addition of purification tags such as histidine tags for simplified isolation .
The G6P (VI) protein plays a vital role in the assembly and release of new phage particles from infected bacterial cells. During phage assembly, all capsid proteins, including G6P (VI), are initially synthesized and accumulated in the inner membrane of the host cell via transmembrane helices. The assembly process begins with the pVII-pIX complex, followed by the helical assembly of pVIII on the single-stranded DNA. The precomplex of pIII-pVI (which includes G6P) finalizes the structure and facilitates the detachment of the newly formed phage particle from the host cell envelope .
Beyond its role in assembly, research suggests that G6P (VI) may also participate in the formation of a pore during the infection process. When a phage infects a bacterial cell, the pIII C-terminal domain is believed to form a pentamer that potentially creates a pore for the phage ssDNA genome to cross the inner membrane. It has been hypothesized that G6P (VI) may assist in this pore formation, although this requires further experimental verification .
G6P (VI) exhibits specific interactions with other phage proteins, most notably with the pIII protein. In the intact phage head, the five pIII C-domains are organized primarily in α-helices and maintain close contact with five units of pVI (G6P). This arrangement has been confirmed through bacterial two-hybrid approaches, which demonstrated that pIII can interact with itself as well as with pVI .
These protein-protein interactions are essential for maintaining the structural integrity of the phage particle and for facilitating the infection process. The coordinated actions of pIII and pVI enable the phage to successfully navigate the complex process of host cell infection, from initial attachment to the release of the viral genome into the bacterial cytoplasm.
Recombinant G6P (VI) is typically produced in E. coli expression systems, where the gene encoding the protein is cloned into appropriate expression vectors. For enhanced purification efficiency, the protein is often fused with affinity tags, most commonly histidine tags at either the N-terminal or C-terminal end. Similar to the approach used for the related If1 phage protein, the expression system allows for the production of the full-length protein (amino acids 1-116) .
Purification of the recombinant protein generally involves affinity chromatography, leveraging the presence of the histidine tag for selective binding to metal-chelating resins. Following elution from the affinity column, the protein typically undergoes additional purification steps such as size exclusion chromatography or ion-exchange chromatography to achieve high purity, generally exceeding 90% as determined by SDS-PAGE analysis .
Recombinant Enterobacteria phage IKe Head virion protein G6P (VI) has several applications in research and biotechnology. These include:
As a recombinant protein, G6P (VI) can be used for the development of specific antibodies that target phage structural proteins. These antibodies find applications in research, diagnostics, and potentially in therapeutic contexts where phage detection or neutralization is desired.
The knowledge gained from studying G6P (VI) and its interactions contributes to the development of protein engineering platforms. Understanding how minor coat proteins interact with other components of the phage structure informs the design of novel protein assemblies with applications in nanobiotechnology and drug delivery systems.
KEGG: vg:1260885
Enterobacteria phage IKe Head virion protein G6P (VI) is a 112-residue, predominantly hydrophobic protein without a signal sequence. The protein is composed of three α-helices arranged in a distinctive "U" shape. The N-terminus forms the longest α-helix spanning approximately 54 residues, which transitions into a shorter 10-residue α-helix, and finally into a C-terminal α-helix of 32 residues. The C-terminus is buried in the center of the pointy tip of the phage structure . This structural arrangement contributes to the protein's role in phage assembly and stability.
The G6P (VI) protein contains distinct functional domains that contribute to its role in phage assembly:
N-terminal domain (α-helix 1): The longest helix forms the primary structural element.
Middle domain (α-helix 2): A short connecting helix that maintains the "U" conformation.
C-terminal domain (α-helix 3): Involved in interactions with other structural proteins.
Recombinant Enterobacteria phage IKe Head virion protein G6P (VI) is typically expressed in E. coli expression systems, with the protein fused to an N-terminal His tag to facilitate purification . The optimal expression conditions include:
| Parameter | Recommended Condition |
|---|---|
| Expression system | E. coli BL21(DE3) or similar strains |
| Induction method | IPTG (0.5-1.0 mM) |
| Temperature | 18-25°C for soluble expression |
| Duration | 16-18 hours |
| Media | LB supplemented with appropriate antibiotics |
Lower temperatures during induction are recommended due to the hydrophobic nature of the protein, which may lead to inclusion body formation at higher temperatures. A gradual induction approach with lower IPTG concentrations may yield better soluble protein expression.
For high-purity G6P (VI) protein preparations suitable for functional studies, a multi-step purification strategy is recommended:
Initial capture: Ni-NTA affinity chromatography utilizing the His-tag
Intermediate purification: Ion exchange chromatography
Polishing step: Size exclusion chromatography
For functional studies examining interactions with other phage proteins, additional considerations include:
Using detergent-based buffers (e.g., containing mild detergents like DDM or LDAO) to maintain protein solubility
Implementing a buffer exchange step to remove imidazole following affinity purification
Considering on-column refolding strategies if the protein is recovered from inclusion bodies
The final product should achieve greater than 90% purity as determined by SDS-PAGE .
Proper handling and storage of purified G6P (VI) protein is critical for maintaining structural integrity and functional activity:
Buffer composition: Store in Tris/PBS-based buffer containing 6% trehalose at pH 8.0
Aliquoting: Divide into single-use aliquots immediately after purification
Storage temperature: Store at -20°C or preferably -80°C for long-term stability
Freeze-thaw cycles: Avoid repeated freeze-thaw cycles as they can cause protein denaturation
Reconstitution: When using lyophilized protein, reconstitute to 0.1-1.0 mg/mL in deionized sterile water
Cryoprotectant: Add glycerol to a final concentration of 5-50% (recommended optimum is 50%) for long-term storage
Working aliquots can be stored at 4°C for up to one week to avoid repeated freezing and thawing of the protein .
G6P (VI) protein forms extensive interactions with other phage proteins, particularly with protein III (pIII). Five copies of the pIII-pVI protein pair are arranged symmetrically to form the pointy tip of the phage with intertwined helices from both proteins . The specific interactions include:
pVI-pVI interactions: Each pVI chain forms seven hydrogen bonds with neighboring pVI chains, concentrated near the C-termini
pVI-pIII interactions: pIII makes 12 hydrogen bonds and 1 salt bridge with its two neighboring pVI molecules
Charge complementarity: The outer surface of pVI is hydrophobic with two distinct rings of positive charge, while pIII forms a negatively charged scaffold around it
These interactions create a structurally stable phage tip where hydrophobic interactions are shielded at the center of the assembled phage, while the solvent-exposed outside remains negatively charged and hydrophilic .
To effectively study G6P (VI) oligomerization and its interactions with other phage proteins, researchers should consider the following techniques:
Cryo-EM has proven particularly valuable for studying the intact phage structure, revealing how G6P (VI) interacts with other proteins in the native environment .
Several factors influence the successful assembly of G6P (VI) into functional phage structures:
Hydrophobicity and charge distribution: The hydrophobic nature of pVI with specific regions of positive charge is essential for proper interaction with pIII
Helical conformation: The predominantly α-helical structure of G6P (VI) is crucial for assembly, as demonstrated by CD studies of wild-type and mutant virions
Environmental conditions: pH, ionic strength, and lipid composition can influence the conformation and assembly of phage coat proteins
Specific amino acid residues: Certain conserved residues play critical roles in maintaining the proper conformation and interactions
The assembly process is highly cooperative, with initial nucleation events followed by rapid extension of the phage structure. Mutations that disrupt the helical conformation or alter the charge distribution can significantly impact assembly efficiency and phage viability .
Several spectroscopic methods have proven valuable for characterizing the structure of G6P (VI):
Circular Dichroism (CD): CD spectroscopy has demonstrated that G6P (VI) adopts a largely helical conformation in both wild-type and mutant virions. This technique can quantify the α-helical content and monitor structural changes under different conditions .
Fluorescence Spectroscopy: Intrinsic tryptophan fluorescence has been used to examine the polarity of the protein environment. Studies of related phage proteins showed that residues within one helical turn can modulate the tryptophan environment .
Nuclear Magnetic Resonance (NMR): NMR studies of phage coat proteins have revealed detailed structural information, including chemical shift changes that indicate conformational alterations. For example, 2D 1H-15N HSQC spectra can detect changes propagated beyond adjacent residues due to mutations .
Cryo-electron microscopy (cryo-EM): This technique has provided high-resolution structural data of the entire phage, revealing the arrangement of G6P (VI) within the assembled virion .
The secondary structure of G6P (VI) features a distinctive three-helix arrangement in a "U" shape, which differs from other phage structural proteins:
Several structural features of G6P (VI) contribute significantly to phage stability:
Helical conformation: The three α-helices provide structural rigidity and create a stable framework for the phage tip .
Hydrogen bonding network: Each pVI chain forms seven hydrogen bonds with neighboring pVI chains, creating a stable interconnected structure .
Hydrophobic core: The arrangement of pVI proteins shields hydrophobic interactions at the center of the assembled phage, preventing unfavorable interactions with the aqueous environment .
Charge complementarity: The positively charged rings on the outer surface of pVI interact with the negatively charged scaffold formed by pIII, stabilizing the protein-protein interfaces .
C-terminal burial: The C-terminus of pVI is buried in the center of the pointy tip, providing additional stability to the structure .
These features work together to create a thermodynamically stable structure that can withstand environmental stresses while maintaining the functional integrity of the phage particle.
G6P (VI) belongs to a family of proteins found in filamentous phages, with both functional similarities and differences compared to homologous proteins:
Several sensitive detection methods can be employed to track G6P (VI) in experimental systems:
For recombinant His-tagged G6P (VI), antibody-based detection methods utilizing the His-tag provide convenient and sensitive detection . For more advanced applications, fluorescently labeled proteins can be tracked in real-time during phage assembly or host interaction studies.
Site-directed mutagenesis is a powerful approach for studying the structure-function relationships of G6P (VI). Based on studies of related phage proteins, researchers should consider:
Target selection:
Key residues at protein-protein interfaces, particularly those involved in hydrogen bonding with pIII
Hydrophobic residues that contribute to core stability
Charged residues in the positive rings that interact with pIII
Mutation strategy:
Conservative substitutions to maintain structural integrity while altering specific properties
Introduction of reporter groups (e.g., fluorescent amino acids) at minimally disruptive positions
Incorporation of crosslinking residues to trap transient interactions
Functional assessment:
Phage assembly efficiency
Thermostability measurements
Spectroscopic analysis of structural changes
Studies of related proteins have shown that certain mutations can have profound effects on protein function. For example, Pro 30 mutations in the related coat protein were found to be critical for viability, rendering the detergent-solubilized coat protein less thermostable and altering the polarity of the Trp 29 environment . Similarly, a Pro 30 Gly mutation exhibited numerous chemical shift changes in the 2D 1H-15N HSQC spectrum, demonstrating that effects can propagate beyond adjacent residues .
Studying protein-DNA interactions involving phage proteins presents several challenges:
Specificity of interactions: While related phage proteins like the IKe DNA binding protein bind cooperatively and with high specificity to single-stranded DNA, characterizing the exact nature of these interactions remains challenging . Approximately four bases of DNA are covered by one monomer of protein, but the structural basis of this specificity is not fully elucidated.
Cooperative binding mechanisms: The cooperative nature of DNA binding by phage proteins complicates the analysis of binding kinetics and thermodynamics. Advanced techniques like single-molecule FRET or atomic force microscopy may be required to fully characterize these cooperative interactions.
Structural studies of protein-DNA complexes: Obtaining high-resolution structures of protein-DNA complexes is technically challenging, particularly for flexible or dynamic complexes.
Role of specific residues: While tyrosine residues are known to be involved in DNA binding in related proteins, with positions 27, 42, and 57 in the IKe DNA binding protein being particularly important , the specific contributions of individual residues remain an area of active research.
Conformational changes in G6P (VI) are critical for phage assembly and function:
Transition from monomer to assembled state: The protein must undergo conformational adjustments as it integrates into the phage structure, forming specific interactions with other pVI proteins and with pIII .
Environmental sensing: The conformation of phage proteins can respond to environmental conditions such as pH, ionic strength, and the presence of other phage components. For example, studies of related coat proteins showed that their conformation differs markedly between the membrane-bound assembly intermediate and the phage capsid .
Sequestration of hydrophobic regions: Both the membrane-bound and virion forms of phage proteins represent successful strategies to sequester hydrophobic regions away from the aqueous environment, but achieve this through different conformational states .
Role in phage tip formation: The specific "U"-shaped conformation of G6P (VI) is essential for forming the characteristic pointy tip of the phage, with five copies of the pIII-pVI pair arranged symmetrically .
Advanced techniques such as hydrogen-deuterium exchange mass spectrometry (HDX-MS) or time-resolved structural methods may be valuable for capturing these conformational transitions during phage assembly.
Several computational approaches can effectively predict interactions between G6P (VI) and other phage components:
Molecular dynamics simulations: MD simulations can model the dynamic behavior of G6P (VI) in different environments and its interactions with other proteins. These simulations can reveal transient interactions and conformational changes that may be difficult to capture experimentally.
Protein-protein docking: Specialized docking algorithms can predict potential binding modes between G6P (VI) and other phage proteins, particularly pIII with which it forms extensive interactions.
Coevolutionary analysis: By analyzing patterns of coevolution in sequence alignments of G6P (VI) and its interaction partners across different phages, researchers can identify potentially interacting residues.
Structure prediction: For phage components with unknown structures, approaches like AlphaFold2 can generate predicted structures that can then be used in interaction studies.
Secondary structure prediction: Methods similar to the Coils 2 program that has been used to identify regions that may form helical coiled-coils in related proteins can provide insights into potential interaction domains.
These computational approaches should be integrated with experimental validation to develop a comprehensive understanding of G6P (VI) interactions within the phage structure.
Robust experimental design for studying G6P (VI) should include several key controls:
Positive controls:
Well-characterized related proteins (e.g., phage fd Head virion protein) with known properties
Synthetic peptides corresponding to specific domains of G6P (VI)
Previously validated functional assays demonstrating expected behavior
Negative controls:
Denatured G6P (VI) protein to confirm structure-dependent functions
Irrelevant proteins of similar size/charge to rule out non-specific effects
Buffer-only controls to establish baseline measurements
Mutation controls:
Conservative substitutions that maintain function
Disruptive mutations at key functional sites
Alanine scanning mutants to identify essential residues
Validation across methods:
Expressing challenging G6P (VI) variants may require optimization strategies:
Expression host selection:
E. coli strains optimized for membrane or hydrophobic proteins (e.g., C41/C43)
Strains with reduced protease activity for unstable variants
Codon-optimized systems for rare codon usage
Fusion partners and solubility tags:
Expression conditions:
Temperature optimization (typically lower temperatures: 18-25°C)
Inducer concentration titration
Extended expression times with lower inducer concentrations
Specialized media formulations
Extraction and solubilization:
Detergent screening for optimal solubilization
Mild extraction conditions to maintain structure
On-column refolding protocols for inclusion bodies
Co-expression strategies:
Co-expression with chaperones (GroEL/ES, DnaK)
Co-expression with natural binding partners (e.g., pIII)
Several approaches can reliably assess the biological activity of purified G6P (VI):
Structural integrity assessment:
Protein-protein interaction assays:
Pull-down assays with potential binding partners (especially pIII)
Surface plasmon resonance to measure binding kinetics
Isothermal titration calorimetry for thermodynamic parameters
Functional complementation:
Phage assembly assays with G6P (VI)-deficient systems
In vitro reconstitution of phage tips
Infectivity assays with reconstructed phage particles
Structural visualization: